Lista de obras - Laura Calabresi - Dominio Público Uruguay

A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene

article

A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis.

artículo científico publicado en 2006

A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred

artículo científico publicado en 2009

A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia

artículo científico publicado en 2007

A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease

artículo científico publicado en 2001

A proteomic portrait of atherosclerosis ⬇️

artículo científico publicado el 19 de febrero de 2013

A woman with low HDL cholesterol and corneal opacity

artículo científico publicado en 2011

Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene

artículo científico publicado en 2002

Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease

artículo científico publicado en 2014

Activation of Lecithin Cholesterol Acyltransferase by a Disulfide-Linked Apolipoprotein A-I Dimer

scientific article published on 01 March 1997

Activity profile of gemfibrozil on the major plasma lipoprotein parameters

article published in 1992

Alterations in the HDL system after rapid plasma cholesterol reduction by LDL-apheresis

artículo científico publicado en 1988

An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia

artículo científico publicado en 2004

Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides

artículo científico publicado en 2007

Apheretic treatment of severe familial hypercholesterolemia: comparison of dextran sulfate cellulose and double membrane filtration methods for low density lipoprotein removal

artículo científico publicado en 1988

ApoA‐IMilanofrom structure to clinical application

Apolipoprotein A-II modulates HDL remodeling in plasma

artículo científico publicado en 1992

Apolipoprotein AIMilano. Partial lecithin: Cholesterol acyltransferase deficiency due to low levels of a functional enzyme

artículo científico publicado en 1990

Apolipoprotein A‐I breakdown is induced by thrombolysis in coronary patients

scientific article published on 01 January 2007

Apolipoprotein E ε4 Allele in Alzheimer's Disease and Vascular Dementia

artículo científico publicado en 1994

Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.

artículo científico publicado en 2002

Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.

artículo científico publicado en 2015

CETP levels rather than polymorphisms as markers of coronary risk: Healthy athlete with high HDL-C and coronary disease—effectiveness of probucol

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

artículo científico publicado en 2014

Cardiovascular risk changes after lipid lowering medications: are they predictable?

artículo científico publicado en 2000

Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol

artículo científico publicado en 1988

Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.

artículo científico publicado en 2011

Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease

artículo científico publicado en 2015

Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes

artículo científico publicado en 2005

Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women

scientific article published on 01 October 1990

Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles

artículo científico publicado en 2010

Denaturation and Self-Association of Apolipoprotein A-I Investigated by Electrophoretic Techniques

artículo científico publicado en 1997

Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein

artículo científico publicado en 2003

Development of a model based on body composition to predict drug kinetics II. Application of the model to the use of digoxin in elderlies

article

Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients

artículo científico publicado en 2013

Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays

artículo científico publicado en 2014

Drug control of reverse cholesterol transport.

artículo científico publicado en 1994

EVIDENCE-BASED MEDICINE CRITERIA APPLIED TO HYPOLIPIDEMIC AND ANTIHYPERTENSIVE DRUG TRIALS: IS DRUG EFFICACY ALWAYS THE SAME?

article

Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys.

artículo científico publicado en 2013

Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin

artículo científico publicado en 2005

Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function

artículo científico publicado en 2015

Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients

artículo científico publicado en 2006

Effects of probucol on the high density lipoprotein system in hypercholesterolaemic patients

scientific article published on 01 January 1989

Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol.

artículo científico publicado en 2002

Endothelial protection by high-density lipoproteins: from bench to bedside

artículo científico publicado en 2003

Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism

scientific article published in Journal of Biological Chemistry

European Lipoprotein Club: Report of the 27th ELC Annual Conference, Tutzing, 6–9 September 2004

European Lipoprotein Club: Report of the 28th ELC Annual Conference, Tutzing, 12–15 September 2005

European Lipoprotein Club: Report of the 29th ELC Annual Conference, Tutzing, 4-7 September 2006.

artículo científico publicado en 2007

European Lipoprotein Club: report of the 26th ELC Annual Conference, Tutzing, 8-11 September 2003.

artículo científico publicado en 2004

Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome.

artículo científico publicado en 2015

Functional LCAT is not required for macrophage cholesterol efflux to human serum

artículo científico publicado en 2008

Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans

Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans

artículo científico publicado en 2009

Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention.

artículo científico publicado en 2014

Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease.

artículo científico publicado en 1995

Genetic determinants of HDL metabolism

artículo científico publicado en 2014

Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease ⬇️

artículo científico publicado el 28 de noviembre de 2011

HDL and atherosclerosis: Insights from inherited HDL disorders.

artículo científico publicado en 2014

HDL and cholesterol handling in the brain

artículo científico publicado en 2014

Hepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in mice

artículo científico publicado en 2014

High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein

artículo científico publicado en 1997

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis

artículo científico publicado en 2016

High-density lipoprotein quantity or quality for cardiovascular prevention?

artículo científico publicado en 2010

High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli

article

High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release

artículo científico publicado en 2003

High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease

artículo científico publicado en 2006

Human apolipoprotein A-II inhibits the formation of pre-β high density lipoproteins

artículo científico publicado en 1996

Human salmonellosis transmitted by a domestic turtle

artículo científico publicado en 1992

Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

artículo científico publicado en 2011

Hypocomplementemic Type II Membranoproliferative Glomerulonephritis in a Male Patient with Familial Lecithin-Cholesterol Acyltransferase Deficiency due to Two Different Allelic Mutations

artículo científico publicado en 2001

Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia

artículo científico publicado en 2002

Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.

artículo científico publicado en 2013

Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease.

artículo científico publicado en 1990

Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection

artículo científico publicado en 2006

Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins

artículo científico publicado en 1997

Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis

artículo científico publicado en 2010

Japan: are statins still good for everybody?

artículo científico publicado en 2006

Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.

artículo científico publicado en 2010

Lipid and Apoprotein Composition of HDL in Partial or Complete CETP Deficiency

article

Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e

artículo científico publicado en 2013

Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families

artículo científico publicado en 2004

Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini

artículo científico publicado en 2002

Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo

artículo científico publicado en 2010

Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux

artículo científico publicado en 2002

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states.

artículo científico publicado en 1998

Molecular characterization of two patients with severe LCAT deficiency

artículo científico publicado en 2007

Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant

artículo científico publicado en 2007

Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia

artículo científico publicado en 2012

Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia

artículo científico publicado en 2008

Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus.

artículo científico publicado en 2013

Off-target effects of thrombolytic drugs: apolipoprotein A-I proteolysis by alteplase and tenecteplase

artículo científico publicado en 2012

Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses

artículo científico publicado en 2000

Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease

artículo científico publicado en 2002

Paradoxical decrease in high-density lipoprotein cholesterol with fenofibrate: a quite rare phenomenon indeed

artículo científico publicado en 2010

Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers

artículo científico publicado en 2004

Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.

artículo científico publicado en 2017

Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk

artículo científico publicado en 2011

Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases.

artículo científico publicado en 2006

Recombinant apolipoproteins for the treatment of vascular diseases

scientific article published on 01 January 1999

Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.

artículo científico publicado en 2013

Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity

artículo científico publicado en 1997

Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency

artículo científico publicado en 2003

Role of LCAT in HDL remodeling: investigation of LCAT deficiency states

scientific article published on 20 December 2006

Severe High-Density Lipoprotein Deficiency Associated With Autoantibodies Against Lecithin:Cholesterol Acyltransferase in Non-Hodgkin Lymphoma

artículo científico publicado en 2012

Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteins.

artículo científico publicado en 2002

Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL.

artículo científico publicado en 2010

Structural features and dynamics properties of human apolipoprotein A-I in a model of synthetic HDL.

artículo científico publicado en 2009

Structure and function of the apoA-IV T347S and Q360H common variants

artículo científico publicado en 2010

Structure of HDL: particle subclasses and molecular components.

artículo científico publicado en 2015

Structure, function and amyloidogenic propensity of apolipoprotein A-I.

artículo científico publicado en 2006

Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injury.

artículo científico publicado en 2006

Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury

artículo científico publicado en 2003

The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux.

artículo científico publicado en 2002

The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential

artículo científico publicado en 2008

The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families

artículo científico publicado en 2005

The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux

artículo científico publicado en 1996

The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction.

artículo científico publicado en 2008

The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic mice.

artículo científico publicado en 2011

Tolerability of fibric acids. Comparative data and biochemical bases.

artículo científico publicado en 1992

Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin

article

Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study.

artículo científico publicado en 2015

eNOS activation by HDL is impaired in genetic CETP deficiency.

artículo científico publicado en 2014

ω-3 Fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers

artículo científico publicado en 1991

Lista de obras de Laura Calabresi

A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene

A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis.

A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred

A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia

A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease

A proteomic portrait of atherosclerosis ⬇️

A woman with low HDL cholesterol and corneal opacity

Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene

Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease

Activation of Lecithin Cholesterol Acyltransferase by a Disulfide-Linked Apolipoprotein A-I Dimer

Activity profile of gemfibrozil on the major plasma lipoprotein parameters

Alterations in the HDL system after rapid plasma cholesterol reduction by LDL-apheresis

An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia

Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides

Apheretic treatment of severe familial hypercholesterolemia: comparison of dextran sulfate cellulose and double membrane filtration methods for low density lipoprotein removal

ApoA‐IMilanofrom structure to clinical application

Apolipoprotein A-II modulates HDL remodeling in plasma

Apolipoprotein AIMilano. Partial lecithin: Cholesterol acyltransferase deficiency due to low levels of a functional enzyme

Apolipoprotein A‐I breakdown is induced by thrombolysis in coronary patients

Apolipoprotein E ε4 Allele in Alzheimer's Disease and Vascular Dementia

Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.

Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.

CETP levels rather than polymorphisms as markers of coronary risk: Healthy athlete with high HDL-C and coronary disease—effectiveness of probucol

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

Cardiovascular risk changes after lipid lowering medications: are they predictable?

Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol

Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.

Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease

Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes

Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women

Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles

Denaturation and Self-Association of Apolipoprotein A-I Investigated by Electrophoretic Techniques

Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein

Development of a model based on body composition to predict drug kinetics II. Application of the model to the use of digoxin in elderlies

Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients

Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays

Drug control of reverse cholesterol transport.

EVIDENCE-BASED MEDICINE CRITERIA APPLIED TO HYPOLIPIDEMIC AND ANTIHYPERTENSIVE DRUG TRIALS: IS DRUG EFFICACY ALWAYS THE SAME?

Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys.

Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin

Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function

Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients

Effects of probucol on the high density lipoprotein system in hypercholesterolaemic patients

Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol.

Endothelial protection by high-density lipoproteins: from bench to bedside

Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism

European Lipoprotein Club: Report of the 27th ELC Annual Conference, Tutzing, 6–9 September 2004

European Lipoprotein Club: Report of the 28th ELC Annual Conference, Tutzing, 12–15 September 2005

European Lipoprotein Club: Report of the 29th ELC Annual Conference, Tutzing, 4-7 September 2006.

European Lipoprotein Club: report of the 26th ELC Annual Conference, Tutzing, 8-11 September 2003.

Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome.

Functional LCAT is not required for macrophage cholesterol efflux to human serum

Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans

Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans

Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention.

Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease.

Genetic determinants of HDL metabolism

Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease ⬇️

HDL and atherosclerosis: Insights from inherited HDL disorders.

HDL and cholesterol handling in the brain

Hepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in mice

High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis

High-density lipoprotein quantity or quality for cardiovascular prevention?

High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli

High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release

High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease

Human apolipoprotein A-II inhibits the formation of pre-β high density lipoproteins

Human salmonellosis transmitted by a domestic turtle

Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals

Hypocomplementemic Type II Membranoproliferative Glomerulonephritis in a Male Patient with Familial Lecithin-Cholesterol Acyltransferase Deficiency due to Two Different Allelic Mutations

Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia

Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.

Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease.

Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection

Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins

Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis

Japan: are statins still good for everybody?

Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.